Passage BIO, Inc. - Common Stock, par value $0.0001 per share (PASG)

CUSIP: 702712100

Q1 2020 13F Holders as of 31 Mar 2020

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
3,182,163
Total 13F shares
29,151,958
Share change
+29,101,958
Total reported value
$458,206,000
Price per share
$15.75
Number of holders
45
Value change
+$457,418,009
Number of buys
44

Quarterly Holders Quick Answers

What is CUSIP 702712100?
CUSIP 702712100 identifies PASG - Passage BIO, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Passage BIO, Inc. - Common Stock, par value $0.0001 per share (PASG) as of Q1 2020

As of 31 Mar 2020, Passage BIO, Inc. - Common Stock, par value $0.0001 per share (PASG) was held by 45 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 29,151,958 shares. The largest 10 holders included ORBIMED ADVISORS LLC, FRAZIER MANAGEMENT LLC, FMR LLC, New Leaf Venture Partners, L.L.C., Vivo Capital, LLC, BOXER CAPITAL, LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), BlackRock Inc., Logos Global Management LP, and ALKEON CAPITAL MANAGEMENT LLC. This page lists 45 institutional shareholders reporting positions in this security for the Q1 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.